Zylox-Tonbridge Medical Tech Co Ltd is a medical device company established in 2012 that develops and commercializes interventional devices for peripheral and neurovascular applications. The company’s product portfolio includes peripheral vascular interventional devices such as stents, balloon catheters, and thrombus aspiration catheters, as well as neurovascular devices including flow diverters, embolization coils, and intracranial stents. Key products include the Thrombite Clot Retriever Device, Penguin Peripheral Venous Stent System, Kylin Flow Diverter, and Mammoth Large Lumen Peripheral Thrombus Aspiration Catheter. The company serves hospitals and physicians in China and international markets, with production bases in China and Germany. It has formed strategic partnerships with Avinger for OCT solutions, Hicicare for vascular guidewires, and Wire Sciences for surgical robotics. The company acquired Optimed to expand its global supply chain and distribution network. Many of its products have received the NMPA Innovative Medical Device designation.

Summarised from the company's own disclosures, fiscal year ended Apr 2026

Industry Medical Devices Homepage zyloxtb.com
Sector Healthcare IR page zyloxtb.com/investor-relations
Tags
peripheral vascular devices, neurovascular devices, stents, balloon catheters, thrombus aspiration, flow diverters, embolization coils, vascular access, ischemic stroke, hemorrhagic stroke, atherectomy, intracranial stents, Thrombite Clot Retriever Device, Penguin Peripheral Venous Stent System, Kylin Flow Diverter, Mammoth Large Lumen Peripheral Thrombus Aspiration Catheter, Orca Balloon Expandable Covered Stent, Otter Thrombectomy Catheter, Self-expandable Aneurysm Embolization Device, OCT-guided Peripheral Vascular Targeted Atherectomy Catheter Series, ZYLOX Venous Stent System, Tonbridge Gekko Coil System, Tonbridge Gycline Microcatheter, Zynlastic peripheral venous stent system, ZYLOX Octoplus IVC Filter, ZENFlow Tiger LD PTA Dilatation Catheter, ZYLOX Phoenix Peripheral Detachable Fibered Coil Embolization System, ZYLOX Unicorn Vascular Closure Device, Pantheris Atherectomy Device, ZENFluxion, ZENFLEX Pro, ZENFLEX Peripheral Stent System, Optimed, Avinger, Hicicare, Wire Sciences, SKY ROAD
Press page —

Metrics

Valuation  
Market cap HK$ 5.68B
Market cap (USD) $ 723.868M
P/E 20.57
PEG —
P/BV 1.60
P/S 4.00
P/OCF 10.40
P/FCF —
Dividend yield 1.4%
Turnover / mcap 0.16%
Returns  
ROE 7.2%
ROI 7.0%
ROIC 7.0%
Profit margin 21.7%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity 3.7%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 41.2%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue 1.057B 782.476M 527.754M 334.09M 177.912M 27.631M
Net profit 229.11M 100.256M -78.734M -113.555M -199.689M -100.468M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Share price 20.67 10.16 9.94 11.53 21.63 —
Price performance 12m 1.08 0.03 -0.19 -0.49 — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Table of Content [Hide
]

Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK) has received CE Mark certification under the European Union Medical Device Regulation (EU MDR) for two of its neurovascular products, the Kylin™ Flow Diverter and the Gekko™ Detachable Coil System.

The certifications expand Zylox-Tonbridge's neurovascular portfolio in Europe and pave the way for commercialization across the 27 EU member states. They also mark another step in the company's international expansion, supporting its efforts to bring more treatment options to physicians and patients worldwide.

  • Kylin™ Flow Diverter

The Kylin™ Flow Diverter features a braided design using platinum-core nitinol DFT wires for enhanced visibility during deployment. Its closed, flared distal end facilitates smooth, controlled opening and supports precise positioning. Since its launch in China in 2024, Kylin™ has been used in more than 10,000 clinical cases, including over 3,000 involving distal small vessels.

  • Gekko™ Detachable Coil System

The Gekko™ Detachable Coil System features an ultra-soft design for gentle placement within the aneurysm. Its mechanical detachment mechanism enables rapid, reliable coil release without the need for a separate detachment device, simplifying the procedure for physicians.

With EU MDR CE Mark certification secured for both products, Zylox-Tonbridge plans to advance their commercialization in Europe and strengthen collaboration with local physicians and partners to support clinical adoption based on local clinical needs.

The company will continue to expand its international operations and strengthen its global competitiveness as it advances its strategy to build a global vascular intervention platform, bringing innovative treatment options to more physicians and patients worldwide.

PREV:

Zylox-Tonbridge Delivers Strong First-Half 2026 Results as International Revenue Surges 349%

NEXT: No information

Return

References

Related Neurovascular Device Products

TrioPath™ Guidewire TrioPath™ Guidewire

ZYLOX Octoplus™ Vena Cava Filter ZYLOX Octoplus™ Vena Cava Filter

Thrombite™ II Clot Retriever Device Thrombite™ II Clot Retriever Device

ZYLOX Unicorn™  Vascular Closure Device ZYLOX Unicorn™ Vascular Closure Device

News from Zylox-Tonbridge

Stay informed with the latest company news from Zylox-Tonbridge.

TonBridge Medical won the Science and Technology Innovation Leader of 2020 and Science and Technology Innovation Product of 2020

TonBridge Medical won the Science and Technology Innovation Leader of 2020 and Science and Technology Innovation Product of 2020 Explore More >

Regional Distribution of the Neurovascular Devices Market

Regional Distribution of the Neurovascular Devices Market Explore More >

Global Market Analysis for Neurovascular Interventions

Global Market Analysis for Neurovascular Interventions Explore More >

ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.



+86-571-8861-0082


[email protected]

Zylox-Tonbridge Industrial Park, No. 270 Shuyun Road, Yuhang District, Hangzhou, Zhejiang, China

Tonbridge Medical optimed

Solutions

Neurovascular Interventions

Ischemic Stroke Hemorrhagic Stroke Intracranial Stenosis Carotid Artery Stenosis Intracranial Access Radial Artery Access

Vascular Interventions

Arterial Venous Hemodialysis Access Other Peripheral-Vascular Vascular Closure Devices

Quick Links

About ESG Patients Investor Relations News Contact Us

Copyright © ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. All Rights Reserved.

Sitemap

Privacy Policy

Legal Statement

Neurovascular Interventions

Ischemic Stroke Hemorrhagic Stroke Intracranial Stenosis Carotid Artery Stenosis Intracranial Access Radial Artery Access

Vascular Interventions

Arterial Venous Hemodialysis Access Other Peripheral-Vascular Vascular Closure Devices

Quick Links

About ESG Patients Investor Relations News Contact Us

Zylox-Tonbridge Industrial Park, No. 270 Shuyun Road, Yuhang District, Hangzhou, Zhejiang, China

[email protected] +86-571-8861-0082

Copyright © ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. All Rights Reserved.

Sitemap Privacy Policy

  • +86-571-8861-0082

We use cookies on this site, including third party cookies, to delivery experience for you.

Accept Cookies

Read Privacy Policy

Prompts

Zylox-Tonbridge Medical Tech Co Ltd. (ticker 2190), listed in Hong Kong.

ETFs Holding Zylox-Tonbridge Medical Tech Co Ltd.

ETF Weight in ETF Shares Market value As of
AVEE 0.03% 19,000 $ 43.735K Nov 16, 2026
DFEM 0.00% 56,500 $ 132.019K Nov 12, 2026
DFAE 0.00% 34,000 $ 79.445K Nov 12, 2026
AVEM 0.00% 196,500 $ 452.315K Nov 16, 2026